insights_auto
Prečo akcie SDZNY stúpli 2,14%?
Preskúmať podrobnejšiechevron_right
SDZNY:OTCMKTS
Sandoz
92,98 USD
arrow_upward
+2,14%(+1,94) 1 d.
16. 10., 16:00:00 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre SDZNY…
Otvoriť
92,15 USD
Vysoká
93,52 USD
Nízka
92,15 USD
Trh. kap.
33,64 mld.
Priem. obj.
27,16 tis.
Objem
24,96 tis.
Max. za 52 týž.
94,15 USD
Min. za 52 týž.
60,40 USD
Akcie v obehu
440,00 mil.
Počet zamestnancov
20 tis.
Otvoriť
92,15 USD
Vysoká
93,52 USD
Nízka
92,15 USD
Trh. kap.
33,64 mld.
Priem. obj.
27,16 tis.
Objem
24,96 tis.
Max. za 52 týž.
94,15 USD
Min. za 52 týž.
60,40 USD
Akcie v obehu
440,00 mil.
Počet zamestnancov
20 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Yahoo! Finance Canada
·
pred 18 minútami
NTHI,VITL,SRAD,HERZ,EFOR,TRIN,FFIN,NXRT,AVBC,CULP,BLCO,BBSI,VSNT,VIRC,GRNT,SSP,GAIA,CSPI,AFCG,AWRE,APCX,KLTR,AUBN,BETR | Stock Prices | Quote Comparison
The Motley Fool
·
pred 25 minútami
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
Simply Wall Street
·
pred 1 hodinou
Is INmune Bio (NASDAQ:INMB) In A Good Position To Deliver On Growth Plans?
Profil
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
Informácie o subjekte Sandoz
Generálny riaditeľRichard Saynor
Zamestnanci20 tis.
Dátum založenia1886
Hlavné sídlo-
Odvetvie-
Websandoz.com